↓ Skip to main content
What is this page? Embed badge

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

Overview of attention for article published in Pediatric Blood and Cancer, December 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
26 Mendeley
Summary X Dimensions citations
So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.